Get Started

ENSC

NASD Ensysce Biosciences, Inc.
Nov 6, 2026 · 2:14 AM ET EOD Market Closed

$0.3610 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3610, $0.0086 below the day’s high of $0.3696

YTD change
-60.76%
vs 20-day SMA
-25.06%
vs 200-day SMA
-14.92%

Price ranges

Previous day
$0.3635 $0.3999
open $0.3950 close $0.3697
-$0.0253 (-6.41%)
Today
$0.3315 $0.3696
open $0.3660 now $0.3610
-$0.0050 (-1.37%)
Past week
$0.3600 $0.4720
from $0.4523 now $0.3610
-$0.0913 (-20.19%)
Past month
$0.3600 $0.6200
from $0.4294 now $0.3610
-$0.0684 (-15.93%)
This year
$0.2300 $1.1200
from $0.9200 now $0.3610
-$0.5590 (-60.76%)

Price & Performance

-0.04 (-9.75%) / 6M

$0.2232$0.3574$0.4915$0.6257May 5Aug 6Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $5,136.0000
  • ENSC is down 61% since the beginning of the year
  • ENSC is down 83% over the past 12 months
  • ENSC is down 16% over the past 1 month
  • 2% of all ENSC investors are betting against ENSC

ENSC reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -82.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.2
Earnings momentum -66.7% Quarterly EPS growth
Quarterly change -66.7%

Valuation

P/E ratio N/A
Enterprise value $4.0M
Beta -0.33

Balance sheet & scale

IncomeN/A
Revenue$4.5M
Cash$676.7K
Debt$197.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $7.0M

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $460.28 -3.80%
MRNA Moderna, Inc. $241.46 -6.55%
RVMD Revolution Medicines, Inc. $177.65 -11.04%
ROIV Roivant Sciences Ltd. $36.62 -4.21%
BNTX BioNTech SE Sponsored ADR $85.86 -5.34%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.